Taxane sensitivity of ovarian carcinoma in vitro

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2475-2479

  Engblom, Pirjo ^a   Rantanen, Virpi ^a   Kulmala, Jarmo ^a   Heiskanen, Jukka ^b   Grenman, Seija ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chemosensitivity in vitro; Clonogenic assay; Docetaxel; Ovarian carcinoma; Paclitaxel

Indexed keywords

CISPLATIN; DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE;

ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GROWTH INHIBITORS; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0030764416     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wani MC, Taylor HL, Wall ME, Coggan P and McPhail AT: Plant antitumor agents VI the isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. McGuire WP, Hoskins WJ, Brady MF et a: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1-6, 1996.
3. Denis JN, Greene AE, Guenard D, Gueritte-Voegelein F, Mangatal L and Potier P: A highly efficient, practical approach to natural taxol. J Am Chem Soc 110: 5917-5919, 1988.
4. Mangatal L, Adeline M-T, Guenard D, Gueritte-Voegelein F and Potier P. Application of the vicinal axyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron 45: 4177-4190, 1989.
5. Colin M, Guenard D, Gueritte-Voegelein F and Polier P. Process for preparing derivatives of baccatin III and of 10 deacetyl baccatin III. US Patent 4924-4012, 1990.
6. R) a review of preclinical and experience. Part II: clinical experence. Anti-Cancer Drugs 6: 356-368, 1995.
7. Hanauske, A-R, Degen D, Hilsenbeck SG, Bissery MC and von Hoff DD: Effects of Taxotere and taxol in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 3: 121-124, 1992.
8. Braakhuis MIM, Hill BT, Dietel M et al: In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumors and normal bone marrow cells. Anticancer Res 14: 205-208, 1994.
9. Kelland LR and Abel G: Comparative in vitro cytotocicity of taxol and taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 30: 444-450, 1992.
10. Engblom P, Rantanen V, Kulmala J and Grenman S. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay. Anticancer Res 16: 1743-1748, 1996.
11. Fogh J, Wright WC and Loveless JD: Absence of HeLa cell contamination in 169 cell Lines derived from human tumors. J Natl Cancer Inst 58: 209-214, 1977.
12. Untch M, Sevin B-U, Perras JP et al: Evaluation of paclitaxel (Taxol), cisplatin and the combination paclitaxel cisplatin in ovarian cancer in vitro with the ATP- cell viability assay. Cynecol Oncol 5: 44-49, 1994.
13. Grènman S, van Dyke D, Worsham MI et al: Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 45: 920-927, 1990.
14. Rantanen V, Grènman S, Kulmala J and Grenman R: Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines. Br J Cancer 69: 482-486, 1994.
15. Bissery M-C. Preclinical pharmacology of docetaxel. Eur J Cancer 31A: 1-6, 1995.
16. Rowinsky EK, Cazenave LA and Donehower RC: Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990.
17. Rantanen V, Grenman S, Kulmala J and Grenman R. Simultaneous cisplatin and radiation in endometrial adenocarcinoma cell lines Acta Oncol 34: 93-98, 1995.
18. Rantanen V, Grenman S, Kulmala J and Grenman R. Endometrial cancer cell lines are sensitive to paclitaxel. Anticancer Research 16: 475-480, 1996.
19. Jaakkola M, Rantanen V, Grènman S, Kulmala J and Grenman R: In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines. Cancer 977: 1940-1946, 1996.
20. Hill BT, Whelan RDH, Shellard SA, McClean S and Hosking LK: Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. Invest New Drugs 12: 169-182, 1994.
21. Alberts DS, Garcia D, Fanta P, Roe D and Salmon SE: Comparative cytotoxicities of taxol and taxotere in vitro against fresh human ovarian cancers. Proc Am Soc Clin Oncol 11: 710-719, 1992.
22. Vogel M, Hilsenbeck SG, Depenbrock H et al: Preclinical activity of taxotere (RP 56976, NCS 628503) against freshly explanted clonogenic human tumor cells: comparison with taxol and conventional antineoplastic agents. Eur J Cancer 29A: 2009-2014, 1993.
23. Griffon G, Merlin J-L, Parache RM, et al. Sensitivity to taxoid derivatives of a newly established human endometrioid ovarian adenocarcinoma radioresistant cell line. Anticancer Res 16: 177-188, 1996.
24. Riou JE, Naudin A and Lavelle F. Effects of taxotere on murine and human tumor cell lines. Biochem Biophys Res Commun 187: 164-170, 1992.
25. Diaz JF and Andreau JM. Assembly of purified GDP-tubulin into microtubules induced by RP 56976 and paclitaxel: reversibility, ligand stoichiometry and competition. Biochemistry 32: 2747-2755, 1993.
26. R) in P388 cell line. Proc Am Assoc Cancer Res 35: 385, 1994.
27. Guenitte-Voegelein F, Guenard D, Lavelle F, Lcgoff MT, Mangatal L and Potier P: Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34: 992-998, 1991.
28. Fromes Y, Gounon P, Bissery M-C and Fellous A: Differential effects of Taxol and Taxotre on Tau and MAP2 containing microtubules. Proc Am Ass Cancer Res 33: 30-55, 1992.
29. R) on human gastric cancers in vitro and in vivo. Eur J Cancer 32A: 226-230, 1996.
30. Nicoletti M, Lucchini V, Incalci M, Giavazzi R: Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts. Eur J Cancer 30A: 691-696, 1994.
31. Kaye SB, Piccart M, Aapro M and Kavanagh JJ: Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. Eur J Cancer 31A: 14-17, 1995.